These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32858422)

  • 21. Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer's Disease.
    Liu X; Liu Y; Liu Q
    Biosensors (Basel); 2023 Apr; 13(5):. PubMed ID: 37232876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid multiplexed detection of beta-amyloid and total-tau as biomarkers for Alzheimer's disease in cerebrospinal fluid.
    Song C; Deng P; Que L
    Nanomedicine; 2018 Aug; 14(6):1845-1852. PubMed ID: 29857195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
    Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of COX-2 Level in Alzheimer's Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target.
    Kumari S; Kaur P; Singh AK; Ashar MS; Pradhan R; Rao A; Haldar P; Chakrawarty A; Chatterjee P; Dey S
    J Alzheimers Dis; 2024; 98(2):699-713. PubMed ID: 38427490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enlightening the advancements in electrochemical bioanalysis for the diagnosis of Alzheimer's disease and other neurodegenerative disorders.
    Serafín V; Gamella M; Pedrero M; Montero-Calle A; Razzino CA; Yáñez-Sedeño P; Barderas R; Campuzano S; Pingarrón JM
    J Pharm Biomed Anal; 2020 Sep; 189():113437. PubMed ID: 32629192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Electrokinetic and Microfluidic Strategies for Detection of Amyloid Beta Peptide Biomarkers: Towards Molecular Diagnosis of Alzheimer's Disease.
    Van Thanh Nguyen N; Taverna M; Smadja C; Mai TD
    Chem Rec; 2021 Jan; 21(1):149-161. PubMed ID: 33112020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
    Prvulovic D; Hampel H
    Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible Immuno-Infrared Sensor for the Detection of Alzheimer's Disease Related Biomarkers.
    Budde B; Schartner J; Tönges L; Kötting C; Nabers A; Gerwert K
    ACS Sens; 2019 Jul; 4(7):1851-1856. PubMed ID: 31241315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmonic Nanoparticles as Optical Sensing Probes for the Detection of Alzheimer's Disease.
    Oyarzún MP; Tapia-Arellano A; Cabrera P; Jara-Guajardo P; Kogan MJ
    Sensors (Basel); 2021 Mar; 21(6):. PubMed ID: 33809416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosensors for detection of Tau protein as an Alzheimer's disease marker.
    Ameri M; Shabaninejad Z; Movahedpour A; Sahebkar A; Mohammadi S; Hosseindoost S; Ebrahimi MS; Savardashtaki A; Karimipour M; Mirzaei H
    Int J Biol Macromol; 2020 Nov; 162():1100-1108. PubMed ID: 32603732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current progress in aptamer-based sensing tools for ultra-low level monitoring of Alzheimer's disease biomarkers.
    Zamanian J; Khoshbin Z; Abnous K; Taghdisi SM; Hosseinzadeh H; Danesh NM
    Biosens Bioelectron; 2022 Feb; 197():113789. PubMed ID: 34798498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers.
    Lee JC; Kim SJ; Hong S; Kim Y
    Exp Mol Med; 2019 May; 51(5):1-10. PubMed ID: 31073121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting Alzheimer's disease biomarkers: From antibodies to new bio-mimetic receptors and their application to established and emerging bioanalytical platforms - A critical review.
    Scarano S; Lisi S; Ravelet C; Peyrin E; Minunni M
    Anal Chim Acta; 2016 Oct; 940():21-37. PubMed ID: 27662756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Femtomolar Detection of Tau Proteins in Undiluted Plasma Using Surface Plasmon Resonance.
    Kim S; Wark AW; Lee HJ
    Anal Chem; 2016 Aug; 88(15):7793-9. PubMed ID: 27399254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease.
    Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P
    J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future.
    Karaboğa MNS; Sezgintürk MK
    J Pharm Biomed Anal; 2022 Feb; 209():114479. PubMed ID: 34861607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
    Mattsson N; Lönneborg A; Boccardi M; Blennow K; Hansson O;
    Neurobiol Aging; 2017 Apr; 52():196-213. PubMed ID: 28317649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
    Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ
    J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers of Alzheimer's disease: the present and the future.
    Lehmann S; Delaby C; Touchon J; Hirtz C; Gabelle A
    Rev Neurol (Paris); 2013 Oct; 169(10):719-23. PubMed ID: 24021316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.